We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$158M
AUM Growth
-$435M
Cap. Flow
-$425M
Cap. Flow %
-268.84%
Top 10 Hldgs %
51.56%
Holding
73
New
22
Increased
6
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$3.42M
2
MASI
Masimo
MASI
+$3.29M
3
ICUI icon
ICU Medical
ICUI
+$3.09M
4
BRKR icon
Bruker
BRKR
+$2.45M
5
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$1.81M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$33.3M
2
LYRA
LYRA THERAPEUTICS INC
LYRA
+$8.79M
3
DXCM icon
DexCom
DXCM
+$4.16M
4
VKTX icon
Viking Therapeutics
VKTX
+$3.27M
5
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$2.86M

Sector Composition

Rank Sector Weight
1 Healthcare 48.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$13.6M 8.61%
25,000
-55,000
-69% -$28.8M
ESTA icon
2
Establishment Labs
ESTA
$2.69B
$10.5M 6.62%
230,093
-31,580
-12% -$1.6M
GKOS icon
3
Glaukos
GKOS
$10.1B
$10.3M 6.52%
87,000
+8,000
+10% +$849K
QQQ icon
4
PUT
Invesco QQQ Trust
QQQ
$480B
$9.58M 6.06%
20,000
-40,000
-67% -$18M
ISRG icon
5
Intuitive Surgical
ISRG
$133B
$8.41M 5.32%
18,900
-5,150
-21% -$2.05M
NTRA icon
6
Natera
NTRA
$39.3B
$7.31M 4.63%
67,500
-4,106
-6% -$417K
MSOS icon
7
AdvisorShares Pure US Cannabis ETF
MSOS
$812M
$5.77M 3.65%
787,000
+207,000
+36% +$1.81M
MASI
8
CALL
DELISTED
Masimo
MASI
$5.6M 3.55%
+44,500
New +$5.86M
QTRX icon
9
Quanterix
QTRX
$177M
$5.41M 3.42%
409,334
+33,349
+9% +$557K
ACWX icon
10
PUT
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
$5.04M 3.19%
+90,000
New +$4.8M
XITK icon
11
PUT
State Street SPDR FactSet Innovative Technology ETF
XITK
$74.6M
$4.64M 2.93%
+50,000
New +$7.13M
RMD icon
12
PUT
ResMed
RMD
$32.4B
$4.59M 2.91%
24,000
-4,000
-14% -$812K
LIVN icon
13
LivaNova
LIVN
$4.29B
$4.3M 2.72%
78,350
-11,801
-13% -$673K
IXP icon
14
PUT
iShares Global Comm Services ETF
IXP
$571M
$4.06M 2.57%
+20,000
New +$1.72M
INSP icon
15
PUT
Inspire Medical Systems
INSP
$1.74B
$4.01M 2.54%
30,000
+12,500
+71% +$2.37M
ICUI icon
16
ICU Medical
ICUI
$4.16B
$3.48M 2.2%
+29,334
New +$3.09M
CSTL icon
17
Castle Biosciences
CSTL
$929M
$3.34M 2.11%
+153,386
New +$3.42M
LUNG icon
18
Pulmonx
LUNG
$85M
$3.25M 2.06%
512,964
+46,177
+10% +$355K
MASI
19
DELISTED
Masimo
MASI
$3.15M 1.99%
+25,000
New +$3.29M
GH icon
20
CALL
Guardant Health
GH
$21.9B
$2.89M 1.83%
100,000
-223,300
-69% -$5.2M
ARKG icon
21
PUT
ARK Genomic Revolution ETF
ARKG
$1.66B
$2.7M 1.71%
115,000
-285,000
-71% -$7.19M
COO icon
22
CALL
Cooper Companies
COO
$14.6B
$2.62M 1.66%
+30,000
New +$2.8M
LIVN icon
23
CALL
LivaNova
LIVN
$4.29B
$2.56M 1.62%
46,700
-98,700
-68% -$5.62M
MDT icon
24
PUT
Medtronic
MDT
$110B
$2.36M 1.49%
+30,000
New +$2.46M
ARKK icon
25
PUT
ARK Innovation ETF
ARKK
$6.05B
$2.2M 1.39%
50,000
-100,000
-67% -$4.47M
1
2 3

Similar funds

GMP
Great Mountain Partners New Haven, Connecticut $15.1M AUM 92.9% 1-Year Est. Return
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
PA
PPM America Chicago, Illinois $16.6M AUM 31.99% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return

Pura Vida Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Pura Vida Investments held 73 positions worth $158M, down 73% from $593M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments withdrew a net $425M in Q2 2024, closing 24 positions and reducing 19 holdings. Its most notable exit was Exact Sciences, an estimated $33.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 24% a quarter earlier.

Against the trend, Pura Vida Investments opened a new position in Castle Biosciences worth $3.34M.

  • Pura Vida Investments's largest Q2 2024 buy was Castle Biosciences: 153,386 shares worth $3.34M.
  • Pura Vida Investments added most to AdvisorShares Pure US Cannabis ETF in Q2 2024, an estimated $1.81M increase.
  • Pura Vida Investments's biggest Q2 2024 reduction was Elanco Animal Health, cutting an estimated $2.18M.
  • Pura Vida Investments fully exited Exact Sciences in Q2 2024, selling an estimated $33.3M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $158M portfolio in Q2 2024.
  • Pura Vida Investments opened 22 new positions and closed 24 in Q2 2024.
  • Pura Vida Investments's portfolio value fell 73% quarter-over-quarter to $158M.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.